Last reviewed · How we verify
NCT06307210
Is Inpatient Rehabilitation Effective for Very Old Patients?
trial testing inpatient rehabilitation in Activity, Motor in 2,270 participants. Completed in 1 January 2023.
31 December 2022
Quick facts
| Lead sponsor | Klinik Valens |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,270 |
| Start date | 1 January 2020 |
| Primary completion | 31 December 2022 |
| Estimated completion | 1 January 2023 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- inpatient rehabilitation
Conditions studied
- Activity, Motor — all drugs for Activity, Motor →
- Elderly Patients — all drugs for Elderly Patients →
- Musculoskeletal Diseases — all drugs for Musculoskeletal Diseases →
Sponsor
Klinik Valens
Who can join
Adults 75 to 100, any sex, with Activity, Motor or Elderly Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this retrospective longitudinal observational study is to compare the effects of physical and mental performance as well as quality of life in patients with neurological and musculoskeletal disorders. The main question it aims to answer is: Do very old patients benefit in a similar way from inpatient rehabilitation like younger patients? Data from about 2000 patients will be retrospectively analyzed. Functional Independence Measurement (FIM), Timed Up and Go Test (TUG), EuroQol 5 Dimensions (EQ-5D) and Patient Reported Outcomes Measurement Information System (PROMIS) were recorded on admission and discharge. Researchers will compare the age group 75 to 84 and 85 to 99 to see if physical and mental performance as well as quality of life will improve.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06307210
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of inpatient rehabilitation
Trials testing the same drug.
- NCT06027333 — Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease · unknown
Other recruiting trials for Activity, Motor
Currently open trials in the same condition.
- NCT07378826 — Power Training Progression Methods · NA · recruiting
- NCT07378813 — Low Versus High Load Training and Parkinson's Disease · NA · recruiting
- NCT07141849 — Periodization and Parkinson's Disease · NA · recruiting
- NCT06821321 — Power or Plyometric Training in Older Adults · NA · recruiting
- NCT06489262 — Efficacy Trial of Healthy Together ("Juntos") · NA · recruiting
Other Klinik Valens trials
Trials by the same sponsor.
- NCT05562414 — Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis · NA · unknown
- NCT05229861 — The Influence of HIIT Versus MCT on Cardiorespiratory Fitness in PPMS · NA · unknown
- NCT04896905 — Rehabilitation After Covid19-Clinical Results and Predictive Factors · completed
- NCT04356248 — Training and Energy Management Education to Improve Quality of Life in Persons With Multiple Sclerosis · NA · completed
- NCT04025385 — High-Intensity-Interval-Training in Geriatric Rehabilitation - A Feasibility Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06307210 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Klinik Valens
- Last refreshed: 12 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06307210.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing